Market Tracker

02/19 1:05pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.89
Delayed Data
As of Feb 16
 +0.04 / +0.82%
Today’s Change
4.01
Today|||52-Week Range
8.38
+5.16%
Year-to-Date

Today’s Trading

Previous close4.85
Today’s open4.84
Day’s range4.77 - 4.93
Volume1,044,328
Average volume (3 months)1,860,835
Market cap$583.0M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)--
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.58-2.37%
TGTXTG Therapeutics Inc-0.45-3.56%
BYSIBeyondspring Inc+0.38+1.45%
EGRXEagle Pharmaceutical...-0.07-0.11%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts